Huntington's disease (HD) is a hereditary neurodegenerative ... The movement disorder is characterized by involuntary movements known as chorea, and by the impairment of voluntary movements. The ...

Symptoms of Huntington's disease appear late in life. Research reveals how DNA repeats grow toxic over time, explaining the delayed onset and disease variability.

I have been talking with a friend at work whose husband has Huntington’s disease. I have learned a lot in the couple of conversations we have had discussing this unforgiving condition. She ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

The FDA has approved Austedo (deutetrabenazine) tablets for the treatment of chorea associated with Huntington’s disease (HD). Formerly known as SD-809, Austedo is the first drug containing ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

Reports Q4 revenue $627.7M, consensus $629.44M. “I’m proud of the tremendous progress we made last year with the continued growth of INGREZZA ...

The fellows gain expertise in diagnosing and treating Parkinson’s disease, atypical Parkinsonian syndromes, dystonia, tremor, Huntington’s disease, chorea, myoclonus, ballism, Tourette syndrome, tics, ...

The fellows gain expertise in diagnosing and treating Parkinson’s disease, atypical Parkinsonian syndromes, dystonia, tremor, Huntington’s disease, chorea, myoclonus, ballism, Tourette syndrome, tics, ...

Drug Significantly Reduces Chorea Symptoms in Patients With Huntington's Disease May 19, 2023 — The drug valbenazine statistically improves chorea, a movement disorder commonly associated with ...

Huntington’s disease used to be called Huntington’s chorea because it is the most commonly inherited condition to lead to the involuntary movements referred to as chorea. A new drug-free ...